Connecting Science and Society Through Comedy
Opinion article by Dr Jessamyn Fairfield, of the National University of Ireland, Galway
Science’s Funny Side
Sometimes, science can feel like a joke. Experiments don’t work, simulations produce physically impossible outcomes, and a question that you thought would take two weeks to answer instead can take two years. All too often we hide the messiness of science, presenting progress as linear rather than admitting the missteps and follies along the way. But surprises and setbacks shape the story of science as a human endeavour, and if we are unwilling to share this side of science, to laugh at ourselves, we risk alienating society from science altogether.
You might be thinking, but science isn’t funny, it’s an important and serious business! In my view, that is exactly why we should find the humour in it. Scientific progress saves lives, and technological advances improve quality of life across the globe. This means that public understanding of and participation in science has never been more important, especially as scientific issues such as climate change and energy usage increasingly impact politics and people worldwide. Research in education tells us that playful approaches to learning information can actually aid in retention and understanding, so educators now encourage learners to generate their own content on a topic – to be able to tell a story. Or write a joke.
What is a joke, after all, but a surprising reversal, a change in viewpoint that completely reframes the information that came before? These sorts of reversals happen in science all the time, and scientists are used to having their viewpoints upended by new data. In fact, many of the skills that are important in science are also important in writing comedy: creativity, a willingness to upend the status quo, and indeed a subversive approach to authority in pursuit of a deeper truth.
But more importantly, consider the audience. When a person listens to a joke, they are waiting for the other shoe to drop and the punchline to be revealed: they are waiting to change their mind. In this era of polarised news and information bubbles, what other approach to communication of complex ideas could possibly be more powerful than comedy?
Bright Club
It is this ethos that underlies Bright Club, a series of variety nights combining academic research and stand-up comedy. I have run Bright Club events in Ireland since 2015, training researchers from science, social science, and humanities and bringing them together with comedians and musicians for thought-provoking shows. The Bright Club format itself was pioneered in the UK by Steve Cross in 2009, and Bright Club events now take place in many European countries. Before each event, academics are trained in stand-up comedy techniques, a skill set which they often find useful in teaching and other science communication events.
In the 60+ events we have held in Ireland, which take place in informal spaces from pubs to music and comedy festivals, we have found an audience which is diverse and excited to hear from academics who reject the notion of the ivory tower. The interdisciplinary nature of the events helps connect science to the broader constellation of human knowledge, drawing in people from all walks of life.
‘Surprises and setbacks shape the story of science as a human endeavour, and if we are unwilling to share this side of science, to laugh at ourselves, we risk alienating society from science altogether.’
We’ve also found that speakers who take part in Bright Club find comedy empowering: not only does it help them to communicate more accessibly, without jargon, but it helps them to communicate authentically, to find their own voices and their own unique perspectives on their own research. Participation in public engagement events like Bright Club often leads to a strengthened sense of agency and scientific identity, but the use of humour adds an extra level to this by allowing researchers to connect their professional selves to their personal selves. Audiences see researchers in their full humanity, and researchers often report that Bright Club is the first time they have felt that this humanity could be part of their work.
Science affects all of society, and hence it is of critical importance to bring researchers into public spaces to engage the public with what they do. Comedy is an invaluable tool for engagement, not least because the audience response adds the element of dialogue. Researchers report that the laughter and comments from the audience, as well as the process of writing jokes and reflecting on their own work, gave them new ideas and perspective on their research. And audiences reported great joy in hearing academic research presented so engagingly, in a fun setting, with a mix of different topics. Facts don’t speak for themselves – they need ambassadors. So, isn’t it time we all started taking ourselves a bit less seriously?
Reference
https://doi.org/10.33548/SCIENTIA405
Creative Commons Licence
(CC BY 4.0)
This work is licensed under a Creative Commons Attribution 4.0 International License. 
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
More articles you may like
Dr Rhett Martin | Governing Nature at the Edge of Collapse
For millions of men, ageing brings with it a set of frustrating and often disruptive urinary symptoms. These symptoms, caused by benign prostatic hyperplasia, or BPH, can affect sleep, confidence, and overall quality of life. Traditionally, treatment follows a familiar path. Patients begin with medications, often for years, and may eventually progress to surgery if symptoms worsen. Yet this pathway is not without its drawbacks. Medications can cause side effects, while surgery carries risks and recovery time. In recent years, a minimally invasive interventional radiology procedure called prostate artery embolisation, or PAE, has begun to challenge this traditional model. At the forefront of this shift is a collaborative research group, led by Dr. Nicholas Brown of the University of Queensland, whose series of P-EASY studies has explored whether PAE could transform how BPH is treated, particularly at earlier stages.
Assoc Prof. Nicholas Brown | Rethinking Prostate Care: A New Frontier in Treating Benign Prostatic Hyperplasia
For millions of men, ageing brings with it a set of frustrating and often disruptive urinary symptoms. These symptoms, caused by benign prostatic hyperplasia, or BPH, can affect sleep, confidence, and overall quality of life. Traditionally, treatment follows a familiar path. Patients begin with medications, often for years, and may eventually progress to surgery if symptoms worsen. Yet this pathway is not without its drawbacks. Medications can cause side effects, while surgery carries risks and recovery time. In recent years, a minimally invasive interventional radiology procedure called prostate artery embolisation, or PAE, has begun to challenge this traditional model. At the forefront of this shift is a collaborative research group, led by Dr. Nicholas Brown of the University of Queensland, whose series of P-EASY studies has explored whether PAE could transform how BPH is treated, particularly at earlier stages.
Jean Lycke | Addressing Unmet Medical Needs in Mucosal Disease: A Close-to-Market Innovation Approach
Recurrent Aphthous Stomatitis (RAS) is an oral condition characterized by one or several painful mucosal ulcers. RAS affects a large proportion of the population and has a point prevalence of approximately 2–3%, daily. The etiology remains unknown, and there is currently no curative treatment. Most patients experience recurring episodes over time, with each episode typically lasting up to a week. Here, we describe the development of a mucoadhesive patch which, when applied over a RAS ulcer, provides rapid pain relief. The patch is easy for patients to apply when symptoms begin and has the potential to be used as an over-the-counter product. The development of the Mucocort mucoadhesive patch is an example of a Close-to-Market innovation strategy that embraces simplicity within a complex healthcare system. By simplifying the product concept, the team has reduced the number of regulatory steps required before market approval. This MedTech/Pharma innovation model, known as the “4R” framework – Re-purposing, Re-formulation, Re-positioning, and Re-patenting – has guided the program from concept to commercialization. In addition to the biodegradable mucoadhesive patch developed for RAS ulcers, the team is extending the innovation concept to a mucoadhesive gel formulation for the prevention and treatment of chemotherapy-induced mucositis. This gel-based program is being commercialized separately through MucoShield.
The Translational Asian Agerelated Macular Degeneration Program Phase 2 (TAAP-2): Reimagining the Future of Vision Care
Age-related macular degeneration, often abbreviated as AMD, is one of the leading causes of vision loss among older adults worldwide. In Asia, where populations are ageing rapidly, its impact is particularly profound. For many, the disease quietly erodes central vision, making everyday activities such as reading, driving, and recognising faces increasingly difficult. Against this backdrop, the Translational Asian Age-related Macular Degeneration Programme, or TAAP for short, has emerged as a bold and ambitious effort to confront the disease headon. Now in its second phase, TAAP-2 represents a significant evolution in both scientific scope and clinical ambition.